Client: Psivant Therapeutics
Agency: Digizyme, Inc.
Contribution: Worked with team members, led storyboarding, and composited animation
Year: 2023
Media: Autodesk Maya, Adobe Illustrator, Adobe After Effects

This pharmaceutical animation describes Psivant Therapeutics’ unique motion-based drug discovery paradigm using their QUAISAR computational platform, and how it is being used to design small molecule allosteric inhibitors of TNF superfamily members.

Storyboard, 2D assets and animation, and final compositing by Brittany Cheung
3D models and animation by Jonathan Khao